306 related articles for article (PubMed ID: 25477897)
41. In-depth characterization of the microRNA transcriptome in a leukemia progression model.
Kuchenbauer F; Morin RD; Argiropoulos B; Petriv OI; Griffith M; Heuser M; Yung E; Piper J; Delaney A; Prabhu AL; Zhao Y; McDonald H; Zeng T; Hirst M; Hansen CL; Marra MA; Humphries RK
Genome Res; 2008 Nov; 18(11):1787-97. PubMed ID: 18849523
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
[TBL] [Abstract][Full Text] [Related]
43. Physiological expression of miR-130a during differentiation of CD34
Mammoli F; Parenti S; Lomiento M; Gemelli C; Atene CG; Grande A; Corradini R; Manicardi A; Fantini S; Zanocco-Marani T; Ferrari S
Exp Cell Res; 2019 Sep; 382(1):111445. PubMed ID: 31152707
[TBL] [Abstract][Full Text] [Related]
44. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications.
Yang X; Wong MPM; Ng RK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients.
Bhise NS; Chauhan L; Shin M; Cao X; Pounds S; Lamba V; Lamba JK
Front Pharmacol; 2015; 6():324. PubMed ID: 26858643
[TBL] [Abstract][Full Text] [Related]
46. New insight into the role of miRNAs in leukemia.
Zhang H; Chen Y
Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
[TBL] [Abstract][Full Text] [Related]
47. MiR-9 functions as a tumor suppressor in acute myeloid leukemia by targeting CX chemokine receptor 4.
Zhu B; Xi X; Liu Q; Cheng Y; Yang H
Am J Transl Res; 2019; 11(6):3384-3397. PubMed ID: 31312352
[TBL] [Abstract][Full Text] [Related]
48. The role of microRNAs in normal and malignant hematopoiesis.
Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic & prognostic role of microRNAs in paediatric acute myeloid leukaemia.
Kumar S; Bakhshi S
Indian J Med Res; 2016 Dec; 144(6):807-814. PubMed ID: 28474617
[TBL] [Abstract][Full Text] [Related]
50. Role of epigenetic in leukemia: From mechanism to therapy.
Liu XL; Liu HQ; Li J; Mao CY; He JT; Zhao X
Chem Biol Interact; 2020 Feb; 317():108963. PubMed ID: 31978391
[TBL] [Abstract][Full Text] [Related]
51. Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?
Abadir E; Gasiorowski RE; Silveira PA; Larsen S; Clark GJ
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32085578
[TBL] [Abstract][Full Text] [Related]
52. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
53. MicroRNAs: key players of normal and malignant myelopoiesis.
Alemdehy MF; Erkeland SJ
Curr Opin Hematol; 2012 Jul; 19(4):261-7. PubMed ID: 22504525
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.
Hartmann JU; Bräuer-Hartmann D; Kardosova M; Wurm AA; Wilke F; Schödel C; Gerloff D; Katzerke C; Krakowsky R; Namasu CY; Bill M; Schwind S; Müller-Tidow C; Niederwieser D; Alberich-Jorda M; Behre G
Cell Death Dis; 2018 Jul; 9(8):814. PubMed ID: 30050105
[TBL] [Abstract][Full Text] [Related]
55. [Screening and expression of CD34(+) cell-specific microRNA in acute myelogenous leukemia].
Wang GP; Zhang SQ; Zhu P; Peng MY; Tan SQ; Yin H; Xu YJ; Chen Y; Chen FP
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):541-5. PubMed ID: 22967414
[TBL] [Abstract][Full Text] [Related]
56. Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cells.
Sparrow RL; O'Flaherty E; Blanksby TM; Szer J; Van Der Weyden MB
Leuk Res; 1997 Jan; 21(1):29-36. PubMed ID: 9029183
[TBL] [Abstract][Full Text] [Related]
57. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
[TBL] [Abstract][Full Text] [Related]
58. miR-139-5p controls translation in myeloid leukemia through EIF4G2.
Emmrich S; Engeland F; El-Khatib M; Henke K; Obulkasim A; Schöning J; Katsman-Kuipers JE; Michel Zwaan C; Pich A; Stary J; Baruchel A; de Haas V; Reinhardt D; Fornerod M; van den Heuvel-Eibrink MM; Klusmann JH
Oncogene; 2016 Apr; 35(14):1822-31. PubMed ID: 26165837
[TBL] [Abstract][Full Text] [Related]
59. MicroRNAs in the midst of myeloid signal transduction.
Stoffers SL; Meyer SE; Grimes HL
J Cell Physiol; 2012 Feb; 227(2):525-33. PubMed ID: 21567394
[TBL] [Abstract][Full Text] [Related]
60. Clonal evolution of preleukemic hematopoietic stem cells in acute myeloid leukemia.
Sykes SM; Kokkaliaris KD; Milsom MD; Levine RL; Majeti R
Exp Hematol; 2015 Dec; 43(12):989-92. PubMed ID: 26455528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
